1. Home
  2. JYNT vs GBIO Comparison

JYNT vs GBIO Comparison

Compare JYNT & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • GBIO
  • Stock Information
  • Founded
  • JYNT 2010
  • GBIO 2016
  • Country
  • JYNT United States
  • GBIO United States
  • Employees
  • JYNT N/A
  • GBIO N/A
  • Industry
  • JYNT Multi-Sector Companies
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • JYNT Miscellaneous
  • GBIO Health Care
  • Exchange
  • JYNT Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • JYNT 163.0M
  • GBIO 145.5M
  • IPO Year
  • JYNT 2014
  • GBIO 2020
  • Fundamental
  • Price
  • JYNT $10.87
  • GBIO $2.18
  • Analyst Decision
  • JYNT Strong Buy
  • GBIO Buy
  • Analyst Count
  • JYNT 2
  • GBIO 4
  • Target Price
  • JYNT $18.00
  • GBIO $7.50
  • AVG Volume (30 Days)
  • JYNT 33.1K
  • GBIO 66.5K
  • Earning Date
  • JYNT 08-08-2024
  • GBIO 08-07-2024
  • Dividend Yield
  • JYNT N/A
  • GBIO N/A
  • EPS Growth
  • JYNT N/A
  • GBIO N/A
  • EPS
  • JYNT N/A
  • GBIO N/A
  • Revenue
  • JYNT $120,071,078.00
  • GBIO $13,174,000.00
  • Revenue This Year
  • JYNT $1.50
  • GBIO $99.36
  • Revenue Next Year
  • JYNT N/A
  • GBIO N/A
  • P/E Ratio
  • JYNT N/A
  • GBIO N/A
  • Revenue Growth
  • JYNT 7.46
  • GBIO 1397.05
  • 52 Week Low
  • JYNT $7.31
  • GBIO $0.86
  • 52 Week High
  • JYNT $17.82
  • GBIO $4.83
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 34.42
  • GBIO 38.71
  • Support Level
  • JYNT $10.89
  • GBIO $2.26
  • Resistance Level
  • JYNT $11.46
  • GBIO $2.49
  • Average True Range (ATR)
  • JYNT 0.31
  • GBIO 0.23
  • MACD
  • JYNT 0.05
  • GBIO -0.03
  • Stochastic Oscillator
  • JYNT 12.16
  • GBIO 1.85

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: